Founded in May 2016 near Seoul, South Korea, 1STBIO is focused on developing breakthrough medicines to address the highest unmet needs in oncology and neurology. < 3 clinical stage programs > - HPK1 inhibitor (I-O): Phase 1/2 in US - c-Abl inhibitor (neuro): Phase 1 in US and Korea - c-Abl PE... Read more
Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
